What's new

Newsroom

Twitter

Videos

Photos

20160128 EGA Regulatory and Scientific Affairs Conferenc

Educational material on biosimilar medicines, developed by IGBA (International Generic and Biosimilar Medicines Association)

2 November 2020

External Resource

Read more

Positioning Statements on Physician-led Switching for Biosimilar Medicines

1 October 2020

Policy

Positioning statements on physician-led switching for biosimilar medicines (October 2021) […]

Read more

Second wave pandemic preparedness: procurement principles

24 August 2020

Policy

Open

Policy Roadmap for Medicines Manufacturing Leadership

6 July 2020

Policy

Open

Call for tenders SANTE/2020/C3/29 for the supply of medicinal products used for intensive care patients subject to the novel coronavirus (COVID-19) disease – policy and technical concerns

25 June 2020

Policy

Open

Preparing for a potential second COVID-19 wave. Joint statement by Medicines for Europe and EFPIA with Kearney

22 June 2020

Policy

Open

LESSONS LEARNED FROM COVID-19 – POLICY PAPER

22 June 2020

Policy

Open

Questions and answers on regulatory expectations for medicinal products for human use during the COVID-19 pandemic

10 April 2020

External Resource

Open

Why is Now the Right Time to Modernise the Eu Variations System?

30 January 2020

Report

Open

AMR Industry Alliance 2020 Progress Report

16 January 2020

Report

Open

Subscribe to our newsletter